Research has shown that protein tyrosine phosphatase 1B (PTP1B) has surfaced as a new and encouraging focal point for therapeutic intervention in the treatment of type 2 diabetes [8,11]. The gene discussed is PTPN1; the disease is type 2 diabetes mellitus.